Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411

Share on StockTwits

Europe's first medical cannabis ETF reaches first anniversary with strong growth, as medical cannabis sector set to grow as major tailwinds fuel reform


London - January 20, 2021 ( Newswire) Investors are pricing in an improved outlook for the cannabis sector under a Democratic House and Presidency, and that this momentum has continued through January, with a surprise Senate takeover by the Democrats, which greatly improves the odds of cannabis reform in the US says a spokesperson for the Medical Cannabis and Wellness UCITS ETF (CBDX).

The European listed Medical Cannabis and Wellness UCITS ETF (CBDX), which was the first cannabis ETF to launch in Europe, has just completed its first year anniversary listing on Deutsche Boerse and London Stock Exchange in January. It is also listed on the SIX Swiss Exchange. The Medical Cannabis and Wellness UCITS ETF, tracks the Medical Cannabis and Wellness Equity Index which has delivered a return of 39.47% over the past three months and 40.41% over the last 12 months[1]. Past performance is no guarantee of future performance. It has grown strongly reflecting investor demand to $28million of assets under management[2]. When you trade ETFs your capital is at risk.

A spokesperson for the CBDX Medical Cannabis ETF says US regulators are increasingly focusing on the potential positive impact of cannabis legislation on job creation, social inequality and tax revenues, and any reforms will provide regulatory precedence for many other countries. Many US lawmakers, at both the Federal and State levels, are moving to relax laws around commercial cannabis usage which is helping the market to grow exponentially.

In addition to this, it says a UK initiative called Project 2021, which aims to develop the biggest database in the world on the effectiveness and tolerability of medical cannabis on patients, should be completed by the end of this year, and it expects this to be a huge boost for the industry. We see pilot projects started in France, Netherlands, and Ukraine also.

Nawan Butt, Portfolio Manager of The Medical Cannabis and Wellness UCITS ETF, said: "We see significant tail winds carrying the cannabis industry through 2021. Momentum in the US is at full swing for legislative reform both at federal and state levels.

"In the UK, incumbents are racing to be the first to list on the LSE, and international supply chains are gaining strength to supply the growing European market."

Nawan Butt said: "The US cannabis trade is now running full steam ahead. With a 'blue wave' there is significant upside for the cannabidiol (CBD) wellness and ancillary services industries in the US, which are sharing the growth rates of the underlying cannabis industry. There is significant momentum not only at the federal level with multiple cannabis bills expected to be tabled soon but also at the state level as pandemic hit government coffers look towards taxation revenues for some relief. States such as New York, Virginia, and even Texas are debating now the advantages of cannabis legalization and its impact on job creation, social inequality, and most importantly tax revenues.

"In the UK, within the first half of this year we expect to see multiple cannabis operators list on the London Stock Exchange.

"Cannabis patient count in the UK is also rising at a consistent pace, and the country's Project 2021 - an initiative that aims to create the largest body of evidence for the effectiveness and tolerability of medical cannabis by the end of this year - should hopefully make both physicians and patients more comfortable with cannabis as a mainstream rather than fringe treatment."

Hector McNeil co-CEO at HANetf said "CBDX was a market first for Europe. It also is a flagship ETF in HANetf's burgeoning, innovative and broad range of thematic ETFs offering exposure to similar mega trends as medical cannabis. CBDX has had superb performance with just under 40% performance over the last 3 months and clearly great tailwinds to see that momentum going forward."

"Before the CBDX medical cannabis ETF launched last year, European investors bought cannabis stock traded mainly in the North American markets. CBDX fixes a big problem for investors and their brokers as it can be hard for them to assess if that company is generating revenues in cannabis activities that may not be legal in Europe but are permitted in the US & Canada. CBDX screening provides comprehensive due diligence at the company level to only allow legal companies under the various European jurisdictions. It also provides diversified exposure to the space in a single trade available across European exchanges and is tradable in GBP, USD, EUR & CHF."

About HANetf

HANetf is an independent provider of UCITS ETFs, working with asset management companies to bring differentiated, modern and innovative exposures to European ETF investors. Via our white-label ETF platform, HANetf provides a complete operational, regulatory, distribution and marketing solution for asset managers to launch and manage UCITS ETFs.

[1] Source: Bloomberg/HANetf as of 31.12.2021

[2] Source: HANetf as of 18.01.2021

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories for Cannabis stocks and Psychedelic Stocks

Buy a cannabis guest post on


Sign up for free stock news alerts at